Rose-Hip Vital® for Osteoarthritis
Osteoarthritis is a degenerative joint disease that mostly affects cartilage, the tissue that covers the end of bones in a joint allowing bones to glide over each other and absorb shock of movement.
It is a condition that affects the whole joint including bone, ligaments and muscles. Osteoarthritis can affect any joint but occurs most often in the knees, hips, finger joints and big toe. Osteoarthritis can develop at any age but tends to be more common in people aged over 40 years or those who have had joint injuries.
The most common symptoms are pain and stiffness in the joints which may affect your ability to carry out normal daily activities such as walking, driving, slicing vegetables or opening jars. Usually the symptoms are more noticeable initially during and after activity and as the disease develops the symptoms become more constant.
A significant 2005 study showed that after just 3 weeks of taking Rose-Hip Vital® with GOPO®, 82% of Osteoarthritis patients reported a reduction in pain. Pain was alleviated to such an extent that 40% reduced their consumption of paracetamol. The study also found that after a 3 month period, there was increased joint mobility, reduced joint stiffness on waking, better management of joint pain and relief from Arthritic pain.
Not only does science support the pain relief benefits of Rose-Hip Vital® with GOPO® for Arthritis sufferers, but a more recent 2011 Swiss study revealed it may help prevent the onset or progression of Arthritis by helping to protect and rebuild cartilage.
Rose-Hip Vital® with GOPO® is backed by more than 30 scientific studies including double blind placebo controlled trials.
Prof Marc Cohen, Professor of Complementary Medicine at RMIT University says “These studies suggest that Rosehip may be an effective first-line therapy for osteoarthritis sufferers. Rosehip has been found to significantly reduce inflammation and pain for people with osteoarthritis.”
Rose-Hip Vital® with GOPO® is more effective than Glucosamine Hydrochloride in reducing osteoarthritic pain.
A meta-analysis of six studies, involving a total of 1222 people, compared the pain reducing effect of glucosamine and Rosehip powder for osteoarthritis. The study found that there was a clinically significant improvement in the group who took our product verses those who took glucosamine.
Glucosamine is ineffective in many patients, especially those with severe OA. The duration of its symptomatic relief also tends to be temporary. There is no evidence that glucosamine or chondroitin is able to result in cartilage repair.